With the advancement in HIV care and the increased life expectancy of HIV-positive individuals, there is a growing concern
about the co-occurrence of metabolic disorders, such as pre-diabetes, among pregnant women living with HIV. Understanding
the prevalence and associated factors of pre-diabetes in this population is crucial for effective management and improved
maternal and fetal outcomes. This cross-sectional study aimed to assess the prevalence of pre-diabetes and its associated
factors among HIV-positive pregnant women attending antenatal clinics in a tertiary healthcare facility. A structured
questionnaire was administered to collect demographic, clinical, and lifestyle data. Fasting plasma glucose levels were
measured, and pre-diabetes was diagnosed according to established criteria. A total of 157 HIV-positive pregnant women
participated in the study. The prevalence of pre-diabetes was found to be 3.8%. Factors significantly associated with prediabetes
included, such as age, BMI, duration of HIV infection, ART regimen, etc. This study highlights a significant
prevalence of pre-diabetes among HIV-positive pregnant women, indicating the importance of routine screening and
comprehensive management strategies in antenatal care settings. Addressing modifiable risk factors identified in this study
could potentially mitigate the burden of pre-diabetes and its associated complications in this vulnerable population. Further
longitudinal studies are warranted to validate these findings and guide tailored interventions for better maternal and fetal
health outcomes